Logo image of CHSCL

CHS INC - CHSINC 7 1/2 PERP (CHSCL) Stock Fundamental Analysis

NASDAQ:CHSCL - Nasdaq - US12542R8034 - Currency: USD

25.48  +0.09 (+0.37%)

Fundamental Rating

4

Taking everything into account, CHSCL scores 4 out of 10 in our fundamental rating. CHSCL was compared to 89 industry peers in the Food Products industry. CHSCL has an average financial health and profitability rating. CHSCL is valued expensive and it does not seem to be growing. CHSCL also has an excellent dividend rating. With these ratings, CHSCL could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CHSCL had a positive cash flow from operations.
In the past 5 years CHSCL has always been profitable.
CHSCL had a positive operating cash flow in each of the past 5 years.
CHSCL Yearly Net Income VS EBIT VS OCF VS FCFCHSCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 7.92%, CHSCL belongs to the top of the industry, outperforming 84.27% of the companies in the same industry.
CHSCL has a Return On Equity of 14.11%. This is in the better half of the industry: CHSCL outperforms 76.40% of its industry peers.
With a Return On Invested Capital value of 5.88%, CHSCL perfoms like the industry average, outperforming 59.55% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CHSCL is below the industry average of 8.94%.
The last Return On Invested Capital (5.88%) for CHSCL is above the 3 year average (5.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROIC 5.88%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
CHSCL Yearly ROA, ROE, ROICCHSCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 3.62%, CHSCL is in the better half of the industry, outperforming 60.67% of the companies in the same industry.
In the last couple of years the Profit Margin of CHSCL has grown nicely.
CHSCL has a Operating Margin of 2.42%. This is comparable to the rest of the industry: CHSCL outperforms 42.70% of its industry peers.
In the last couple of years the Operating Margin of CHSCL has grown nicely.
Looking at the Gross Margin, with a value of 5.06%, CHSCL is doing worse than 85.39% of the companies in the same industry.
CHSCL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
CHSCL Yearly Profit, Operating, Gross MarginsCHSCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 1 2 3 4 5

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHSCL is creating some value.
Compared to 1 year ago, CHSCL has an improved debt to assets ratio.
CHSCL Yearly Shares OutstandingCHSCL Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCL Yearly Total Debt VS Total AssetsCHSCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.82 indicates that CHSCL is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CHSCL (2.82) is better than 66.29% of its industry peers.
The Debt to FCF ratio of CHSCL is 1.02, which is an excellent value as it means it would take CHSCL, only 1.02 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.02, CHSCL belongs to the best of the industry, outperforming 87.64% of the companies in the same industry.
A Debt/Equity ratio of 0.19 indicates that CHSCL is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.19, CHSCL is in the better half of the industry, outperforming 66.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Altman-Z 2.82
ROIC/WACC1.02
WACC5.75%
CHSCL Yearly LT Debt VS Equity VS FCFCHSCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B 10B

2.3 Liquidity

CHSCL has a Current Ratio of 1.58. This is a normal value and indicates that CHSCL is financially healthy and should not expect problems in meeting its short term obligations.
CHSCL has a Current ratio (1.58) which is comparable to the rest of the industry.
A Quick Ratio of 0.91 indicates that CHSCL may have some problems paying its short term obligations.
CHSCL has a Quick ratio (0.91) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.91
CHSCL Yearly Current Assets VS Current LiabilitesCHSCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

More info and screens

1

3. Growth

3.1 Past

CHSCL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.09%.
Measured over the past years, CHSCL shows a small growth in Revenue. The Revenue has been growing by 6.88% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCL Yearly Revenue VS EstimatesCHSCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCL Price Earnings VS Forward Price EarningsCHSCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHSCL is valued cheaply inside the industry as 96.63% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CHSCL is valued cheaply inside the industry as 97.75% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.14
EV/EBITDA 0.96
CHSCL Per share dataCHSCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1K 2K 3K

4.3 Compensation for Growth

The decent profitability rating of CHSCL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

7

5. Dividend

5.1 Amount

CHSCL has a Yearly Dividend Yield of 7.41%, which is a nice return.
CHSCL's Dividend Yield is rather good when compared to the industry average which is at 4.35. CHSCL pays more dividend than 94.38% of the companies in the same industry.
CHSCL's Dividend Yield is rather good when compared to the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 7.41%

5.2 History

CHSCL has been paying a dividend for at least 10 years, so it has a reliable track record.
As CHSCL did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years9
CHSCL Yearly Dividends per shareCHSCL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

11.11% of the earnings are spent on dividend by CHSCL. This is a low number and sustainable payout ratio.
DP11.11%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCL Yearly Income VS Free CF VS DividendCHSCL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B
CHSCL Dividend Payout.CHSCL Dividend Payout, showing the Payout Ratio.CHSCL Dividend Payout.PayoutRetained Earnings

More info and screens

CHS INC - CHSINC 7 1/2 PERP

NASDAQ:CHSCL (4/22/2025, 8:00:00 PM)

25.48

+0.09 (+0.37%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-01 2025-04-01
Earnings (Next)07-08 2025-07-08
Inst Owners13.41%
Inst Owner Change0%
Ins Owners0.03%
Ins Owner Change0%
Market Cap312.64M
Analysts0
Price TargetN/A
Short Float %0.36%
Short Ratio1.19
Dividend
Industry RankSector Rank
Dividend Yield 7.41%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP11.11%
Div Incr Years0
Div Non Decr Years9
Ex-Date06-13 2025-06-13 (0.46875)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.14
P/OCF 0.11
P/B 0.03
P/tB 0.03
EV/EBITDA 0.96
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)178.98
FCFY702.44%
OCF(TTM)233.94
OCFY918.12%
SpS3422.59
BVpS877.08
TBVpS877.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROCE 7.68%
ROIC 5.88%
ROICexc 6.17%
ROICexgc 6.17%
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
FCFM 5.23%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
ROICexc(3y)5.96%
ROICexc(5y)4.73%
ROICexgc(3y)6.08%
ROICexgc(5y)4.81%
ROCE(3y)7.21%
ROCE(5y)6.02%
ROICexcg growth 3Y73.02%
ROICexcg growth 5Y27.66%
ROICexc growth 3Y72.21%
ROICexc growth 5Y27.52%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
F-Score6
Asset Turnover2.19
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Debt/EBITDA 1.33
Cap/Depr 122.19%
Cap/Sales 1.61%
Interest Coverage 250
Cash Conversion 182.9%
Profit Quality 144.65%
Current Ratio 1.58
Quick Ratio 0.91
Altman-Z 2.82
F-Score6
WACC5.75%
ROIC/WACC1.02
Cap/Depr(3y)76.68%
Cap/Depr(5y)79.95%
Cap/Sales(3y)0.94%
Cap/Sales(5y)1.13%
Profit Quality(3y)105.8%
Profit Quality(5y)111.96%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.39%
EBIT growth 3Y69.09%
EBIT growth 5Y26.62%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y620.74%
FCF growth 3Y59.62%
FCF growth 5Y30.48%
OCF growth 1Y387.5%
OCF growth 3Y44.56%
OCF growth 5Y25.04%